Severe Hypercholesterolemia Associated with Steroid-Refractory Acute Liver GVHD: Unusual Complication of Allogeneic Hematopoietic Cell Transplantation

Bhagyashree Deshmankar, Craig E. Eckfeldt, Graf Oliver, Aleksandr Lazaryan, Nelli Bejanyan

Research output: Contribution to journalArticlepeer-review

Abstract

Severe hypercholesterolemia is an uncommon complication of allogenic hematopoietic cell transplantation (HCT). Treatment options for hypercholesterolemia due to liver graft-versus-host disease (GVHD) are limited because many antilipidemic medications are known to worsen hepatic functions. We report our experience on a case of a 38-year-old male with Philadelphia chromosome positive acute lymphoblastic leukemia presenting with steroid-refractory hepatic and lower gastrointestinal acute GVHD after matched sibling donor peripheral blood myeloablative HCT who developed severe hypercholesterolemia (>1,000mg/dl). The patient was effectively treated with extracorporeal photopheresis for GVHD and severe hypercholesterolemia resolved after weeks of therapy with lipoprotein apheresis.

Original languageEnglish (US)
Article number118
JournalOBM Transplantation
Volume4
Issue number3
DOIs
StatePublished - Oct 2020

Bibliographical note

Publisher Copyright:
© 2020 by the author.

Keywords

  • Acute GVHD
  • lipid apheresis
  • severe hypercholesterolemia

Fingerprint

Dive into the research topics of 'Severe Hypercholesterolemia Associated with Steroid-Refractory Acute Liver GVHD: Unusual Complication of Allogeneic Hematopoietic Cell Transplantation'. Together they form a unique fingerprint.

Cite this